Hubbry Logo
Notalgia parestheticaNotalgia parestheticaMain
Open search
Notalgia paresthetica
Community hub
Notalgia paresthetica
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Notalgia paresthetica
Notalgia paresthetica
Notalgia paresthetica
View on Wikipedia
from Wikipedia
Notalgia paresthetica
Other namesNotalgia paraesthetica
Notalgia Paresthetica
SpecialtyNeurology

Notalgia paresthetica or notalgia paraesthetica (NP) (also known as "hereditary localized pruritus", "posterior pigmented pruritic patch", and "subscapular pruritus"[1]) is a chronic sensory neuropathy. Notalgia paresthetica is a common localized itch, affecting mainly the area between the shoulder blades (especially the T2–T6 dermatomes) but occasionally with a more widespread distribution, involving the shoulders, back, and upper chest.[2]: 402  The characteristic symptom is pruritus (itch or sensation that makes a person want to scratch) on the back, usually on the left hand side below the shoulder blade (mid to upper back). It is occasionally accompanied by pain, paresthesia (pins and needles), or hyperesthesia (unusual or pathologically increased sensitivity of the skin to sensory stimuli, such as pain, heat, cold, or touch), which results in a well circumscribed hyperpigmentation of a skin patch in the affected area.

Causes

[edit]

The causes of this condition have not yet been completely defined.[3] Patients are usually older persons.[4]

The correlation of notalgia paresthetica localization with corresponding degenerative changes in the spine suggests that spinal nerve impingement may be a contributing cause. According to Plete and Massey, "The posterior rami of spinal nerves arising in T2 through T6 are unique in that they pursue a right-angle course through the multifidus spinae muscle, and this particular circumstance may predispose them to harm from otherwise innocuous insults of a varied nature." Patients may have other conditions that predispose them to peripheral neuropathies (nerve damage).[citation needed]

Diagnosis

[edit]

Possible differential diagnoses are:[5]

Treatment

[edit]

Therapy for notalgia paresthetica is directed at controlling symptoms, as no cure exists for the condition. Available treatments include local anesthetics, topical capsaicin,[6][7] topical corticosteroids,[8] hydroxyzine, oxcarbazepine, palmitoylethanolamide and gabapentin. Paravertebral nerve block and botulinum toxin injections may also be helpful.

Some patients treated with low concentration topical capsaicin reported pain, burning, or tingling sensations with treatment, and symptoms returned within a month of ceasing treatment.[9] Oxcarbazepine was reported to reduce the severity of symptoms in a few cases.[10] One patient has been treated with "paravertebral nerve blocks, with bupivacaine and methylprednisolone acetate injected into the T3–T4 and T5–T6 intervertebral spaces" [11] Hydroxyzine has also been used with considerable success in some cases as long as the pills are used daily.

High concentration topical capsaicin (8%, Qutenza) have been shown to be highly effective in treating neuropathic itch in some patients[12][13] (including notalgia paresthetica) as well as in a recent proof-of-concept study.[14]

Most recently intradermal injections of botulinum toxin type A (Botox) have been tried with some success. Even though botulinum normally wears off in three to six months, the treatment appears to be long term, and it has been theorised that botulinum type A effects lasting change in pain signaling.[15]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Notalgia paresthetica

View on Grokipedia
from Grokipedia
Notalgia paresthetica is a sensory neuropathy characterized by typically unilateral localized pruritus (itching) on one side of the upper back, usually between the shoulder blade and spine, often accompanied by burning, tingling, pain, or altered sensation. The condition has no primary rash, although chronic scratching may lead to secondary skin changes such as discoloration, hyperpigmentation, or excoriations. Also known as thoracic entrapment , it results from or compression of the posterior rami of spinal nerves, mainly at T2-T6 levels. The condition primarily affects adults over 50, with a strong predominance, and accounts for about 8% of chronic pruritus cases. It is often linked to spinal issues like degenerative changes or herniated discs, though other factors such as posture or repetitive strain may contribute. While not dangerous, it can persist for months to years, significantly affecting ; skin changes from scratching occur in many cases, and associated sensory alterations are common. It is rare in children except when associated with type 2A. Diagnosis relies on clinical history and examination, with used if spinal is suspected. There is no cure, but symptom relief includes topical and oral medications, , and interventional options, with varying efficacy; recent research explores new agents like for itch reduction.

Overview

Definition

Notalgia paresthetica is classified as a chronic sensory neuropathy or neuropathic that primarily affects the skin of the upper back, particularly in the infrascapular region. It manifests as localized pruritus resulting from dysfunction of sensory , without involvement of primary motor deficits. This condition is associated with the posterior rami of thoracic spinal T2 through T6. The term "notalgia paresthetica" was first introduced in 1934 by dermatologist M. Astwazaturow, who described cases of unilateral itching on the back in the absence of primary skin lesions. This historical observation highlighted the neuropathic origin of the pruritus, distinguishing it from dermatological disorders driven by cutaneous pathology. Unlike other pruritic conditions such as or , notalgia paresthetica features secondary skin changes—like , excoriations, or macular discoloration—that arise solely from habitual scratching in response to the underlying nerve irritation, rather than representing the initial disease process.

Epidemiology

Notalgia paresthetica is a subtype of chronic neuropathic pruritus. Chronic pruritus has a lifetime incidence exceeding 20% in the general , with neuropathic forms accounting for approximately 8% of chronic pruritus cases. Despite this, the true prevalence of notalgia paresthetica remains underreported and underdiagnosed, largely due to its benign, self-limiting nature and overlap with other pruritic conditions that lead to underrecognition in clinical practice. The condition predominantly affects adults, with a mean age of onset between 50 and 60 years, though cases have been documented in individuals over 40 and rarely in younger patients, including as early as age 6. It occurs two to three times more frequently in females than in males, potentially influenced by reporting biases or anatomical differences, and shows no clear racial or geographic predilections. Notalgia paresthetica is typically unilateral, most commonly affecting the left side of the back in right-hand-dominant individuals, suggesting a possible association with the contralateral side to the dominant hand. Key risk factors include advancing age and female sex, alongside potential links to degenerative changes in the cervical or thoracic spine, such as vertebral or herniated discs, which may irritate involved nerves; it is rare in children.

Pathophysiology and Etiology

Anatomy Involved

Notalgia paresthetica primarily involves the medial aspect of the infrascapular region, located on the upper back below the , within the dermatomes supplied by the upper thoracic spinal nerves. This area receives sensory innervation from the posterior rami of the thoracic spinal nerves T2 through T6, which are responsible for cutaneous sensation in the dorsal midline and paraspinal regions of the upper back. These posterior rami arise as the initial branches of the spinal nerves immediately after their exit from the intervertebral foramina, dividing into lateral and medial branches to innervate the skin, muscles, and joints of the posterior . The spinal origins of these nerves lie in the thoracic segments of the spinal cord, where the T2-T6 nerve roots emerge from the cord and pass through the respective intervertebral foramina. Upon exiting, the posterior rami course posteriorly and superiorly, penetrating the deep layers of the erector spinae muscle group, including the multifidus spinae, at acute or right angles before branching medially toward the skin. This anatomical trajectory positions the nerves in close proximity to surrounding musculoskeletal structures, facilitating their sensory distribution to the infrascapular skin without motor involvement. Potential sites for mechanical interaction with these nerves include the ligamentum flavum, which forms part of the posterior spinal canal boundary in the thoracic region, as well as the facet joints and paraspinal muscles such as the erector spinae and multifidus. Additionally, structures in the cervicothoracic junction, particularly at levels C4 through C6, may exert indirect influence due to their proximity and shared innervation pathways with the upper thoracic nerves.

Mechanisms and Causes

Notalgia paresthetica is characterized by a core mechanism of sensory neuropathy resulting from impingement or irritation of the posterior rami of the thoracic spinal nerves, typically T2 through T6, which disrupts normal sensory signaling to the skin of the upper back. This nerve dysfunction leads to dysregulated signaling in unmyelinated C-fibers, the primary mediators of itch transmission, causing aberrant itch sensations and phenomena such as alloknesis, where non-itchy stimuli provoke pruritus. The affected nerves follow a vulnerable anatomical path, turning approximately 90 degrees to penetrate the multifidus spinae muscle, predisposing them to compression. Pathogenic processes involve nerve entrapment due to acute angulation within paraspinal muscles, often exacerbated by surrounding changes like spasms or that further irritate the dorsal rami. Bifunctional nerve fibers capable of transmitting both and signals contribute to the mixed sensory symptoms, while central in the amplifies these perceptions, leading to heightened responsiveness to stimuli. Increased dermal innervation and neurogenic release of may also play a role in local and pruritus. Common causes include degenerative vertebral changes, such as , , , or herniated discs at cervicothoracic levels (e.g., C6-C7), which compress exiting . Muscle spasms in the paraspinal region or fibrotic bands can similarly entrap , while associated conditions encompass genetic factors like multiple endocrine neoplasia type 2A (MEN2A), metabolic disorders including mellitus, and prior herpes zoster infection in the affected dermatome. exposure often exacerbates symptoms by increasing nerve irritability and pruritus intensity. Recent insights highlight the concept of skin-itch-spine syndrome (SISS), which frames notalgia paresthetica as part of a continuum linking spinal pathologies directly to cutaneous manifestations, emphasizing the role of underlying vertebral degeneration in symptom persistence.

Clinical Presentation

Symptoms

Notalgia paresthetica is primarily characterized by intense, localized pruritus in the upper back, specifically along the medial aspect of the inferior within the T2–T6 dermatomes. Patients often describe this as a burning or crawling sensation, akin to an insect bite or sting, which can be severe and persistent. There is typically no primary rash or cutaneous lesion, as the condition is neuropathic in origin; however, chronic scratching may lead to secondary skin changes such as hyperpigmentation, excoriations, or lichenification. According to a 2024 survey of dermatologists across eight countries, pruritus is the most common symptom, followed by and sensitive skin; the most burdensome symptoms include pruritus, burning or hot sensation, and painful or raw skin. Associated sensory disturbances include such as tingling or numbness, as well as pain ranging from a dull ache to sharp sensations, and occasionally cold or foreign body feelings. These symptoms may occur alongside or tenderness in the affected area. The condition typically presents unilaterally, most commonly on the left side, though bilateral cases are reported, and symptoms are often intermittent with episodic flares lasting from months to years, with a median duration of about 2.8 years. Exacerbations can be triggered by heat, sweating, or temperature changes, and the pruritus may intensify during or periods of distraction due to unconscious scratching. Patients experience a high burden from the dominant , which interferes with , concentration, and daily activities, leading to frustration, irritation, and reduced . In a qualitative study of 30 individuals, 70% reported mood disturbances such as , and 40% noted disruption, with many relying on tools like back scratchers for relief. The chronic, unreachable nature of the symptom often results in significant emotional and functional impact.

Physical Findings

Patients with notalgia paresthetica typically exhibit no primary cutaneous lesions on , such as vesicles, scales, or inflammatory eruptions, with observed changes arising secondarily from chronic rubbing or scratching due to pruritus. A characteristic finding is a hyperpigmented macule or patch, often tan or and measuring 1-10 cm in diameter, located in the infrascapular region medial to the ; this may be accompanied by lichenification or linear excoriations in longstanding cases. Palpation of the affected area frequently elicits localized tenderness, and paraspinal muscles in the cervical or thoracic region may demonstrate spasm or tightness. The Apley's scratch test, involving adduction and internal rotation of the shoulder to reach the contralateral scapula, serves as a rudimentary maneuver to localize the site and may reproduce discomfort during the attempt to access the pruritic area. No systemic signs, such as lymphadenopathy or generalized rash, are observed, reflecting the condition's focal neuropathy.

Diagnosis

Clinical Evaluation

The clinical evaluation of notalgia paresthetica begins with a detailed history to characterize the sensory symptoms and identify potential contributing factors. Patients typically report chronic, intermittent pruritus localized to the mid-upper back, medial to the , often lasting months to years and more commonly unilateral. Clinicians should inquire about the duration and intensity of pruritus, associated sensations such as burning, tingling, or numbness, and exacerbating factors including , which can intensify itching, or poor posture, which may irritate underlying nerves. Additionally, assessment for associated spinal symptoms, such as or , helps guide further evaluation. Physical examination focuses on confirming the localized nature of symptoms and identifying secondary changes from chronic scratching. Palpation of the affected back area often elicits tenderness or reproduces the pruritus, with the site typically corresponding to the T2-T6 dermatomes. Dermatomal mapping can delineate the involved sensory distribution, while Apley's scratch test—requiring adduction and internal rotation of the arm—assesses the patient's ability to reach and point to the precise pruritic spot, often revealing diminished reach on the affected side. No primary cutaneous lesions are present, but secondary findings such as , lichenification, or excoriations may be noted in up to 76% of cases; neurocutaneous testing, including pinprick or light touch, may demonstrate in the area. Imaging and laboratory tests are rarely indicated for straightforward cases, as the diagnosis relies on clinical features. , MRI, or CT scans of the cervical or thoracic spine should be considered only if is suspected, such as in the presence of or neurological deficits, to evaluate for degenerative changes or impingement. Routine tests are not required, though screening for rare associations like multiple endocrine neoplasia type 2A (via calcitonin levels) may be warranted in younger patients with suggestive features. Notalgia paresthetica is a clinical , confirmed by the characteristic localized symptoms aligning with the T2-T6 dermatomes without evidence of primary . A 2020 radiological study of 45 patients found that 87% had underlying spinal pathologies, supporting the use of in select cases to corroborate involvement, though it is not essential for .

Differential Diagnosis

Notalgia paresthetica (NP) must be differentiated from other conditions presenting with localized pruritus, pain, or sensory disturbances in the upper back or similar regions, as misdiagnosis can delay appropriate management. Key neuropathic differentials include brachioradial pruritus, which involves cervical nerve roots (typically C5-C8) and manifests on the arms or forearms rather than the infrascapular area, often exacerbated by sun exposure; meralgia paresthetica, caused by lateral femoral cutaneous nerve entrapment and limited to the lateral thigh with burning paresthesias; and , which is typically bilateral, symmetric, and affects distal extremities in a stocking-glove distribution due to . Unlike NP, these conditions have distinct anatomical distributions and underlying etiologies, such as metabolic factors in . Skin disorders mimicking NP often feature primary lesions absent in NP, where only secondary hyperpigmentation or lichenification from chronic scratching occurs. Macular amyloidosis presents with pruritic, rippled hyperpigmented patches on the upper back but shows amyloid deposits on biopsy, distinguishing it from NP's neuropathic origin. Tinea versicolor and contact dermatitis exhibit scaling, hypopigmentation, or erythematous reactions with identifiable fungal elements or allergens, respectively, whereas NP lacks such primary eruptions. Neurodermatitis or lichen simplex chronicus involves an itch-scratch cycle leading to thickened plaques without underlying neuropathy, and parapsoriasis or early mycosis fungoides may show subtle scaling or plaques with potential progression to lymphoma, requiring histopathological confirmation. Systemic or infectious conditions like herpes zoster can simulate NP post-resolution, with unilateral dermatomal pain or pruritus, but typically follow an acute vesicular phase and may leave scarring, unlike the chronic, non-eruptive course of NP. Imaging such as MRI is useful to exclude compressive spinal lesions, including tumors or degenerative changes mimicking NP's sensory neuropathy, particularly if symptoms extend beyond the T2-T6 dermatomes or include radicular signs. Overall, NP is distinguished by its isolated infrascapular location, absence of primary skin changes, and sensory findings without motor involvement.

Management

Non-Pharmacological Approaches

Non-pharmacological approaches form the cornerstone of initial for notalgia paresthetica, focusing on alleviating symptoms through physical interventions, sensory modulation, and behavioral adjustments that target potential impingement and sensory irritation without relying on medications. These strategies emphasize conservative measures to improve posture, reduce muscle tension, and interrupt itch-pain cycles, often yielding symptomatic relief in a majority of cases when implemented early. Physical therapy plays a central role, incorporating and strengthening exercises aimed at the thoracic spine and surrounding musculature to relieve nerve compression. Specific protocols include pectoral muscle stretches, strengthening, and postural correction exercises, which address underlying spinal misalignment or muscle imbalances contributing to the condition. In clinical reports, such interventions have demonstrated effectiveness, though benefits may wane upon discontinuation without ongoing maintenance. maneuvers and therapy complement these efforts by promoting muscle relaxation and spinal mobility, further supporting relief from localized pruritus and . Modalities such as (TENS) offer non-invasive pain and itch modulation by delivering low-level electrical impulses to disrupt aberrant nerve signals. Studies indicate significant reductions in pain intensity with TENS application over 15 sessions, particularly when combined with kinesiotherapy. and provide additional options, targeting trigger points in paraspinal muscles to enhance circulation and reduce neuropathic sensations, with up to 75% of treated cases showing complete relief in some studies. Lifestyle modifications emphasize avoiding exacerbating factors and incorporating routines to minimize symptom flares. Patients are advised to steer clear of heat exposure, which can intensify pruritus, and instead apply cool compresses or ice packs to override itch signals through cold-induced . Regular exercise routines focused on posture maintenance and weight control further aid in preventing nerve irritation. Reassurance and regarding the benign, self-limiting nature of the condition are integral, often sufficient to reduce scratching behaviors and improve adherence to these approaches, as supported by clinical guidelines.

Pharmacological and Interventional Therapies

Pharmacological and interventional therapies for notalgia paresthetica are typically considered when non-pharmacological approaches provide insufficient relief, targeting neuropathic and associated symptoms through modulation or direct intervention. Topical agents form the initial line of pharmacological treatment, with cream (0.025-0.075%) applied to desensitize affected nerves by depleting , a key mediator of pruritus. Clinical reports indicate variable efficacy, with some patients experiencing reduced itching after 3-6 weeks of application three to five times daily, though initial burning sensations are common. Lidocaine patches (5%) offer for temporary symptom relief, as demonstrated in case studies where application alleviated pruritus without systemic side effects. Systemic medications address underlying neuropathic mechanisms more broadly, with or as first-line options due to their in reducing pruritus scores. , dosed at 300-900 mg/day in divided doses, has shown the highest among oral agents in recent reviews, with improvements noted within one month and mild gastrointestinal side effects as the primary concern. , starting at low doses of 75-150 mg/day and titrated up to 300 mg/day, provides similar benefits through modulation, particularly in refractory cases. Antidepressants such as (topical 5% cream or oral low-dose) modulate via histamine receptor blockade, offering adjunctive relief when combined with anticonvulsants. Interventional therapies are reserved for persistent symptoms, including botulinum toxin A injections into the affected area to inhibit neurotransmitter release and reduce neural hyperexcitability. Early case series reported significant itch reduction lasting months, though outcomes vary, with a 2025 case report highlighting its emerging role in chronic, refractory notalgia paresthetica. Nerve blocks targeting thoracic rami with local anesthetics provide targeted relief by interrupting aberrant signaling, as evidenced by successful paravertebral applications in small cohorts. For associated hyperpigmentation, cryolipolysis may address secondary skin changes by reducing nerve density, showing partial resolution in isolated reports.

Prognosis and Impact

Disease Course

Notalgia paresthetica typically presents with an insidious onset in middle-aged adults, often between 40 and 80 years of age, manifesting as unilateral pruritus in the upper back region that persists for months to years. The condition follows a chronic trajectory, marked by episodes of remission and , with symptoms waxing and waning over time. occurs rarely, and the disorder seldom resolves entirely without intervention. The disease course can be influenced by factors such as progressive spinal degeneration, including or vertebral changes, which may exacerbate nerve compression and intensify symptoms. Physical stressors, including poor posture or activities that strain the thoracic spine, are also associated with symptom flares. Although not curable, the condition is generally controllable through targeted management strategies, allowing for mitigation of symptoms despite its persistent nature. A 2023 phase 2 of oral reported modestly greater reductions in intensity scores compared to among patients with notalgia paresthetica. Monitoring involves periodic clinical follow-up to assess spinal , particularly in patients with underlying degenerative changes, as ongoing can help identify triggers related to posture or activity levels. The is benign, with no associated increase in mortality, though symptoms often persist in most cases. A 2023 review highlights that while the condition endures chronically, treatments achieve symptom reduction with varying success in select studies.

Complications and Quality of Life

Notalgia paresthetica can lead to several secondary complications arising from chronic scratching and excoriations of the affected . These include secondary bacterial infections due to breaches in the barrier from excessive pruritus-induced trauma. Additionally, persistent scratching may result in the development of , characterized by thickened, hyperkeratotic plaques, or prurigo nodules, which are firm, pruritic papules formed from repeated mechanical irritation. In rare instances, chronic localized friction and keratin degradation from scratching can progress to , a form of cutaneous amyloid deposition presenting as hyperpigmented, scaly patches. The condition significantly impairs , primarily through the unrelenting burden that disrupts , heightens anxiety, and limits daily functioning. Nocturnal exacerbations often lead to disturbances from involuntary , while the persistent discomfort contributes to emotional distress and reduced productivity. A 2024 case-control study of 26 patients with notalgia paresthetica found that (DLQI) scores were markedly higher in those with comorbid (median 8.00 vs. 3.00 in notalgia paresthetica patients without comorbid ), underscoring the amplified impact on overall well-being, alongside dermatologist-observed and postinflammatory pigmentation changes. Psychosocially, patients frequently experience frustration stemming from the condition's underdiagnosis in settings, where chronic symptoms are often dismissed or misattributed, prolonging and eroding trust in healthcare providers. To address these multifaceted effects, interprofessional care involving dermatologists, neurologists, and providers is recommended to facilitate holistic and improve patient outcomes. Early intervention is crucial to prevent complications by curtailing chronic scratching before secondary changes develop, while on the benign nature of the condition and coping strategies—such as avoiding triggers and using emollients for barrier support—can enhance adherence and mitigate burden.

References

  1. https://my.clevelandclinic.org/health/diseases/24850-notalgia-paresthetica
  2. https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-020-01773-6
  3. https://skinsight.com/skin-conditions/notalgia-paresthetica/
  4. https://pubmed.ncbi.nlm.nih.gov/27396529/
  5. https://www.mountsinai.org/about/newsroom/2023/new-formulation-of-fda-approved-drug-shows-encouraging-results-for-treating-a-common-itch-condition
  6. https://www.ncbi.nlm.nih.gov/books/NBK470597/
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC6544103/
  8. https://www.consultant360.com/articles/notalgia-paresthetica
  9. https://emedicine.medscape.com/article/1599159-overview
  10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955802/
  11. https://www.mdpi.com/2039-7283/13/1/29
  12. https://www.cureus.com/articles/9157-notalgia-paresthetica-a-novel-approach-to-treatment-with-cryolipolysis
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC7913999/
  14. https://dpcj.org/index.php/dpc/article/download/dermatol-pract-concept-articleid-dp0301a02/dp0301a02-pdf/11299
  15. https://medicaljournalssweden.se/actadv/article/view/44444/51918
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC9955802/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC9256643/
  18. https://doi.org/10.2340/actadv.v104.39941
  19. https://www.dermatologyadvisor.com/home/decision-support-in-medicine/dermatology/notalgia-paresthetica/
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC3663387/
  21. https://emedicine.medscape.com/article/1599159-differential
  22. https://dermnetnz.org/topics/notalgia-paraesthetica
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC9051159/
  24. https://pubmed.ncbi.nlm.nih.gov/30439740/
  25. https://emedicine.medscape.com/article/1599159-treatment
  26. https://jag.journalagent.com/z4/download_fulltext.asp?pdir=agri&plng=eng&un=AGRI-28159
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC11064992/
  28. https://drbaileyskincare.com/blogs/blog/itchy-back-phenomenon-the-constant-hard-to-reach-itch-find-it-again-friday
  29. https://www.apollohospitals.com/diseases-and-conditions/notalgia-paresthetica
  30. https://pubmed.ncbi.nlm.nih.gov/1521492/
  31. https://www.dermatologyadvisor.com/home/decision-support-in-medicine/[dermatology](/page/Dermatology)/notalgia-paresthetica/
  32. https://pubmed.ncbi.nlm.nih.gov/36189717/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC4148269/
  34. https://www.odermatol.com/odermatology/20214/9.Treatment-SenerS.pdf
  35. https://pubmed.ncbi.nlm.nih.gov/24378421/
  36. https://jamanetwork.com/journals/jamadermatology/fullarticle/654292
  37. https://www.cureus.com/articles/420995-botulinum-toxin-for-the-treatment-of-chronic-notalgia-paresthetica-a-case-report
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC5705169/
  39. https://www.nejm.org/doi/full/10.1056/NEJMoa2210699
  40. https://emedicine.medscape.com/article/1599159-clinical
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC11144133/
  42. https://pubmed.ncbi.nlm.nih.gov/34424886/
Add your contribution
Related Hubs
User Avatar
No comments yet.